Editorial: Gastrointestinal cancer immunotherapy: from drug resistance mechanisms to overcoming strategies

• Tao Shi,
• Hanbing Wang,
• Jia Wei,
• Jinyan Wang,
• Yibo Fan,
• Chunlei Zheng,
• Xiaofang Che,
• Xiaofang Che,
• Xiaofang Che

Affiliations

Tao Shi

Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China

Hanbing Wang

Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China

Jia Wei

Department of Oncology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China

Jinyan Wang

Department of Immunology, Basic School of Medicine, China Medical University, Shenyang, China

Yibo Fan

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

Chunlei Zheng

Department of Oncology, Shanghai Electric Power Hospital, Shanghai, China

Xiaofang Che

Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China

Xiaofang Che

Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China

Xiaofang Che

Clinical Cancer Research Center of Shenyang, the First Hospital of China Medical University, Shenyang, China